Oyster Point Pharma, Inc. Business Finance Contracts & Agreements
8 Contracts & Agreements
- Credit Agreements (1 contract)
- Investor Rights Agreements (1)
- Stock Agreements (4)
- Underwriting Agreements (2)
- Waiver and Amendment, dated as of October 19, 2021, by and among Oyster Point Pharma, Inc., OrbiMed Royalty & Credit Opportunities III, LP. and the other parties thereto (Filed With SEC on October 19, 2021)
- Form of Restricted Stock Unit Grant Notice and (Filed With SEC on August 5, 2021)
- Form of Stock Option Grant Notice and Option Agreement for the 2021 Inducement Plan (Filed With SEC on August 5, 2021)
- Form of Underwriting Agreement, including Form of Lock-up Agreement (Filed With SEC on May 12, 2020)
- 2019 Employee Stock Purchase Plan, to be in effect upon the completion of this offering (Filed With SEC on October 21, 2019)
- Form of Underwriting Agreement, including Form of Lock-up Agreement (Filed With SEC on October 21, 2019)
- Specimen common stock certificate of the Registrant (Filed With SEC on October 15, 2019)
- Amended and Restated Investor Rights Agreement among the Registrant and certain of its stockholders, dated February 15, 2019 (Filed With SEC on October 4, 2019)
